Latest News about CMPS
Recent news which mentions CMPS
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
February 13, 2023
From Benzinga
10 Short Squeeze Candidates To Watch This Week: Getty, Lannett, AirSculpt And More
February 13, 2023
From Benzinga
7 Long-Term Stocks to Buy With Your Tax Refund
February 12, 2023
From InvestorPlace
Cybin, Seelos Therapeutics Among Top Psychedelic Movers Of Today
February 10, 2023
From Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
February 09, 2023
From Benzinga
Psychedelic Stock Gainers And Losers From February 8, 2023
February 08, 2023
From Benzinga
Psychedelic Stock Gainers And Losers From February 7, 2023
February 07, 2023
From Benzinga
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
February 07, 2023
From Motley Fool
7 Tempting Sin Stocks to Buy for Promising Profits
February 06, 2023
From InvestorPlace
Mind Medicine, GH Research Among Top Psychedelic Movers Of Today
February 06, 2023
From Benzinga
EXCLUSIVE: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions
February 06, 2023
Tickers
CMPS
From Benzinga
The 7 Most Promising Psychedelic Stocks to Buy in February
February 05, 2023
From InvestorPlace
Psychedelic Stock Gainers And Losers From February 3, 2023
February 03, 2023
From Benzinga
Psychedelic Stock Gainers And Losers From February 2, 2023
February 02, 2023
From Benzinga
Psychedelic Stock Gainers And Losers From February 1, 2023
February 01, 2023
From Benzinga
GH Research, Mind Medicine Among Top Psychedelic Movers Of Today
January 31, 2023
From Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
January 30, 2023
From Benzinga
Top 3 Psychedelic Storylines To Watch In 2023
January 29, 2023
From Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
January 27, 2023
From Benzinga
Psychedelic Stock Gainers And Losers From January 26, 2023
January 26, 2023
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2023
January 24, 2023
From Benzinga
Atai Life Sciences Investor Christian Angermayer Addresses Recent Trial Results And Pipeline Outlook
January 24, 2023
From Benzinga
Psychedelic Stock Gainers And Losers From January 23, 2023
January 23, 2023
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From January 19, 2023
January 19, 2023
From Benzinga
Psychedelics Market Could Reach $12B By 2029, Says New Report
January 19, 2023
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.